KENNEY EDWARD F 4
4 · ONYX PHARMACEUTICALS INC · Filed Oct 2, 2007
Insider Transaction Report
Form 4
KENNEY EDWARD F
EVP, Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2007-10-01$20.81/sh+3,000$62,430→ 30,250 total - Sale
Common Stock
2007-10-01$43.40/sh−3,000$130,200→ 27,250 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-10-01−3,000→ 31,000 totalExercise: $20.81Exp: 2015-08-31→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares vest monthly from the date of grant at a rate of 1/48th per month over a period of 48 months.